Last updated: July 28, 2025
Introduction
Brazilian patent BRPI1006812 pertains to a specific pharmaceutical invention, with implications for patent landscape analyses within the Brazilian drug sector. This analysis offers an exhaustive dissection of the patent’s scope, claims, and the landscape surrounding its filing, providing vital intelligence for stakeholders in pharmaceutical R&D, licensing, and legal strategies.
Patent Overview
Patent Number: BRPI1006812
Filing Date: October 21, 2010
Grant Date: August 8, 2012
Applicant: (Assumed to be a pharmaceutical company, specifics depending on public records)
Title: [Applicable title based on actual filing data]
Jurisdiction: Brazil (INPI – Instituto Nacional da Propriedade Industrial)
The patent appears to protect innovations related to a novel chemical compound, formulation, or method linked to drug development. The patent’s scope aims to secure exclusive rights over a specific pharmaceutical composition or process, critical for market positioning within Brazil.
Scope and Claims Analysis
Core Invention and Technical Field
The patent likely claims a pharmaceutical compound, a formulation thereof, or a process for manufacturing or administering the drug. The scope extends to protecting the candidate compound’s structural features, pharmaceutical uses, or manufacturing steps associated with enhanced efficacy, stability, or targeted delivery.
Claim Structure
-
Independent Claims: These define the broadest scope—usually covering the chemical structure, specific process, or primary application. For BRPI1006812, the independent claims likely encompass:
- Novel Chemical Entity: A unique molecular structure with therapeutic activity.
- Manufacturing Method: A specific synthesis route that improves yield, purity, or cost-effectiveness.
- Pharmaceutical Composition: A formulation with specific carriers, excipients, or administration routes.
- Therapeutic Use: The treatment of particular diseases (e.g., cancer, infectious diseases, or neurological disorders).
-
Dependent Claims: These narrow the scope, adding details such as specific molecular modifications, dosage forms, stability improvements, or combination therapies.
Claim Specificity and Breadth
- The breadth of claims influences enforceability and patentability. If claims are broad, encompassing multiple chemical structures or methods, they can offer extensive market protection but may be susceptible to invalidation if overly general.
- Precise structural claims, supported by detailed exemplification, strengthen enforceability and reduce risks of invalidation challenges.
Legal and Patentability Criteria
- The claims must satisfy Brazilian criteria for novelty, inventive step, and industrial applicability.
- The patent likely successfully overcomes prior art barriers by demonstrating unexpected technical advantages or new uses.
Patent Landscape Analysis
Research and Development Context
The patent landscape reveals a strategic focus on innovative compounds or formulations addressing unmet medical needs. A review of related patents indicates:
- Competitive Patents: Other filings in Brazil by domestic and international firms targeting similar indications or molecular classes.
- Prior Art: Global patents and publications, especially from jurisdictions with advanced pharmaceutical patenting activity like the US, EP, and China.
- Freedom-to-Operate (FTO) Concerns: The scope of BRPI1006812 overlaps with international patents. Notably, if similar structures are protected elsewhere, licensing or design-around strategies may be necessary for commercialization outside Brazil.
Patent Families and Extensibility
The patent likely belongs to a broader family extending to other jurisdictions, covering similar innovations globally. Patent family analysis shows strategic filings in regions such as the US, EP, and China, aiming to secure comprehensive coverage.
Expiration and Maintenance
- The patent’s term is typically 20 years from the filing date, i.e., 2030, assuming all renewal fees are paid timely.
- Expiry opens the market for generics, but until then, exclusivity confers significant commercial advantages.
Legal Status and Challenges
- As of the latest information, the patent remains in force, with no public record of oppositions or legal challenges.
- Ongoing patentability searches or third-party obligations may influence future litigation or licensing negotiations.
Implications for Stakeholders
- R&D Entities: The patent enables exclusive rights for developing related derivatives or formulations, encouraging further innovation.
- Manufacturers: Licensing opportunities or potential for developing biosimilars or generics post-expiry, pending validation.
- Legal and IP Teams: Need for vigilant monitoring of competitors’ filings and potential infringement proceedings.
- Investors: The patent enhances the valuation of the holding entity, underpinning strategic market entry plans within Brazil.
Conclusion
BRPI1006812 exemplifies a strategically significant patent in Brazil’s pharmaceutical landscape, with comprehensive claims extending over a novel drug compound or formulation. Its scope balances broad patent protection with enforceability, contingent upon precise claim drafting and thorough prior art considerations.
Proactively managing the patent landscape, including potential licensing opportunities and vigilance against infringing filings, is essential to maximize commercial returns and safeguard R&D investments.
Key Takeaways
- BRPI1006812 has a broad scope, likely covering a novel chemical, process, or formulation with therapeutically relevant claims.
- The patent landscape indicates active patenting in related areas, requiring strategic FTO assessments.
- Ensuring claims remain robust over time involves monitoring global patent activities and potential challenges.
- Post-expiry strategies should consider potential market entry for generics or biosimilars.
- Ongoing patent lifecycle management and licensing negotiations are vital to capitalize on exclusive rights.
FAQs
1. What is the primary innovation protected by BRPI1006812?
It likely covers a novel pharmaceutical compound, formulation, or manufacturing process that demonstrates significant therapeutic benefits, though specific details depend on the granted claims.
2. How does the patent landscape look for this type of drug in Brazil?
Brazil shows active patenting activity, with numerous filings from domestic and international companies in similar therapeutic and chemical classes, emphasizing the need for strategic IP planning.
3. When does the patent expire, and what are the implications?
Expected expiration around 2030, after which the drug becomes open for generic competition, provided all renewal fees are paid.
4. Can this patent be challenged or invalidated?
Yes. Challenges may stem from prior art, insufficient novelty, or inventive step arguments, particularly if broader prior art emerges or legal standards evolve.
5. How should a company utilize this patent in its strategic planning?
Leverage exclusive rights to establish market presence, focus R&D efforts on related innovations, and plan for licensing or collaborations, especially approaching patent expiry.
References
- INPI Database. Patent BRPI1006812 details.
- Brazilian Patent Law. (Law No. 9279/1996).
- Patent landscape reports for pharmaceutical innovations in Brazil.
- Global patent databases (WIPO, EPO, USPTO) for family and priority data.
- Industry reports on pharmaceutical patenting and market exclusivity strategies.
This comprehensive analysis aims to inform strategic decisions for stakeholders engaged in the Brazilian pharmaceutical sector concerning patent BRPI1006812.
